对于eGFR的多基因风险得分与功能衰竭时的年龄有关
Kane E Collins1,2,3, Edmund Gilbert1,2, Vincent Mauduit4
1School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Journal of nephrology
|March 3, 2025
概括
估计膜过率 (eGFR) 降低的多基因风险得分与早期的功能衰竭有关. 较高的分数预测功能衰竭的发生时间大约提前两年,突出显示了对疾病进展的遗传影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 慢性病 (CKD) 具有复杂的遗传基础,涉及单基因和多基因因素.
- 慢性病的进展受高血压,糖尿病和蛋白尿等临床因素的影响,所有这些都是通过多基因风险评分来量化的遗传成分.
研究的目的:
- 调查CKD相关特征的多基因风险得分与衰竭发病的年龄之间的关联.
- 确定遗传倾向是否影响功能衰竭发病的时间.
主要方法:
- 利用了来自12个队伍的10,586名功能衰竭患者的全基因组基因型数据.
- 计算了包括高血压,白蛋白尿和降低eGFR在内的特征的多基因风险得分,使用已确定的权重.
- 采用后勤回归来分析多基因风险得分与衰竭年龄之间的关联,分层由原发性病.
主要成果:
- 对于降低eGFR的多基因风险评分最高的个体比其他人早大约两年 (49.9岁对47.9岁) 经历衰竭.
- 降低eGFR多基因风险得分的每一个标准偏差增加与60岁前功能衰竭的更高几率相关 (OR=1.05).
- 高降低的eGFR多基因风险得分显著增加了早期功能衰竭的几率 (OR=1.26).
结论:
- 降低EGFR多基因风险评分是导致功能衰竭发育年龄变化的重要因素.
- 基因倾向,通过多基因风险得分来衡量,在功能衰竭发病的时间上起作用.
更多相关视频
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
2.3K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
526
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
63
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
63
01:11Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71